In re: National Prescription Opiate Litigation

Wright, Curtis (Purdue) (2018-12-19) Transcript

Northern District of Ohio, ohnd-1:2017-md-02804

Current View

Full Text

Case:Highly 1:17-md-02804-DAP Doc #: Confidential - 2177-20 SubjectFiled: 08/12/19 1Confidentiality to Further of 84. PageID #: 322527 Review 1 UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF OHIO 2 EASTERN DIVISION 3 ************************** 4 IN RE: NATIONAL MDL No. 2804 5 PRESCRIPTION OPIATE LITIGATION Case No. 6 1:17-MD-2804 ************************* 7 THIS DOCUMENT RELATES TO Hon. Dan A. Polster 8 ALL CASES 9 ************************** 10 HIGHLY CONFIDENTIAL - SUBJECT TO 11 FURTHER CONFIDENTIALITY REVIEW 12 13 VIDEOTAPED DEPOSITION OF 14 CURTIS WRIGHT, IV, M.D., M.P.H. 15 16 Wednesday, December 19th, 2018 17 9:01 a.m. 18 19 Held At: 20 Grappone Conference Center 21 70 Constitution Avenue 22 Concord, New Hampshire 23 24 REPORTED BY: 25 Maureen O'Connor Pollard, RMR, CLR, CSR Golkow Litigation Services Page 1 (1) Case:Highly 1:17-md-02804-DAP Doc #: Confidential - 2177-20 SubjectFiled: 08/12/19 2Confidentiality to Further of 84. PageID #: 322528 Review Page 2 Page 4 1 APPEARANCES: 1 APPEARANCES (Continued): 2 2 FOR THE PLAINTIFFS: FOR UCB, INC.: 3 LINDA SINGER, ESQ. 3 TINA SCHAEFER, ESQ. (Telephonically) JENNA N. FORSTER, ESQ. HUGHES HUBBARD & REED LLP 4 DAVID A. BENNER, ESQ. 4 2345 Grand Boulevard MOTLEY RICE LLC Kansas City, Missouri 64108 5 401 Ninth Street, NW, Suite 1001 5 816-709-4159 Washington, DC 20004 tina.schaefer@hugheshubbard.co, 6 202-386-9626 6 lsinger@motleyrice.com 7 7 jforster@motleyrice.com FOR ABBOTT LABORATORIES AND ABBOTT LABORATORIES, dbenner@motleyrice.com 8 INC.: 8 JOHN MCCAULEY, ESQ. (Telephonically) 9 FOR THE TENNESSEE PLAINTIFFS: 9 VENABLE LLP MICHAEL G. STEWART, ESQ. 750 East Pratt Street, Suite 900 10 BRANSTETTER, STRANCH & JENNINGS, PLLC 10 Baltimore, Maryland 21202 223 Rosa L. Parks Avenue 410-244-7400 11 Nashville, Tennessee 37203 11 jmccauley@venable.com 615-254-8801 12 12 mstewart@bsjfirm.com FOR ENDO PHARMACEUTICALS INC., ENDO HEALTH 13 13 SOLUTIONS INC., PAR PHARMACEUTICAL COMPANIES, FOR THE DEPONENT: INC. (f/k/a PAR PHARMACEUTICAL HOLDINGS, INC.) 14 GUY PETRILLO, ESQ. 14 ERIC SHAPLAND, ESQ. (Telephonically) PETRILLO KLEIN & BOXER LLP ARNOLD & PORTER KAYE SCHOLER LLP 15 655 Third Avenue 15 777 South Figueroa Street New York, New York 10017 Los Angeles, CA 90017-5844 16 212-370-0330 16 213.243.4238 gpetrillo@pkbllp.com Eric.Shapland@arnoldporter.com 17 18 FOR PURDUE PHARMA: 17 MARINA SCHWARZ, ESQ. 18 19 DECHERT LLP FOR ROCHESTER DRUG COOPERATIVE: 1095 Avenue of the Americas 19 LUCY ONYEFORO, ESQ. (Telephonically) 20 New York, New York 10036 LYNNE FISCHMAN UNIMAN, ESQ. 212-698-3500 20 (Telephonically) 21 marina.schwarz@dechert.com ALLEGAERT BERGER & VOGEL LLP -and- 21 111 Broadway 22 ERIK W. SNAPP, ESQ. New York, New York 10006 DECHERT LLP 22 212-571-0550 23 35 West Wacker Drive lonyeforo@abv.com Chicago, Illinois 60601 23 luniman@abv.com 24 312-646-5800 24 erik.snapp@dechert.com VIDEOGRAPHER: David Kim 25 25 Page 3 Page 5 1 APPEARANCES (Continued): 1 INDEX 2 FOR McKESSON CORPORATION: 2 EXAMINATION PAGE 3 ALISON DiCURCIO, ESQ. (Telephonically) 3 CURTIS WRIGHT, IV, M.D., M.P.H. COVINGTON & BURLING LLP 4 BY MS. SINGER 13 4 One CityCenter 5 BY MR. STEWART 241 850 Tenth Street, NW 6 BY MS. SINGER 326 5 Washington, DC 20001-4956 7 202-662-5518 6 adicurcio@cov.com 8 7 9 EXHIBITS FOR CARDINAL HEALTH, INC.: 10 NO. DESCRIPTION PAGE 8 ANDREW C. McBRIDE, ESQ. (Telephonically) WILLIAMS & CONNOLLY LLP 11 Purdue-Wright-1 Amended Notice of 9 725 Twelfth Street, N.W. Deposition................. 13 Washington, DC 20005 12 10 202-434-5452 Purdue-Wright-2 Dr. Wright's Curriculum amcbride@wc.com 11 13 Vitae, Bates 12 FOR VALIDUS PHARMACEUTICALS: PPLPC013000116251 through MAURA BURKE, ESQ. (Telephonically) 14 258........................ 26 13 FOX ROTHSCHILD, LLP 2000 Market Street 15 Purdue-Wright-3 Executive Profile of 14 Philadelphia, Pennsylvania 19103 Curtis Wright, MD 215-299-2000 16 prepared by Heidrick & 15 mburke@foxrothschild.com Struggles, Bates 16 FOR AMERISOURCEBERGEN DRUG CORPORATION: 17 ENDO-OPIOID-MDL-03004266 17 RYAN BLAKE, ESQ. (Telephonically) through 4276............... 58 REED SMITH LLP 18 18 Three Logan Square Purdue-Wright-4 Project Team Contact 1717 Arch Street, Suite 3100 19 Philadelphia, Pennsylvania 19103 19 Report, Bates 215-851-8100 PKY180764184 through 4186.. 91 20 rblake@reedsmith.com 20 21 Purdue-Wright-5 Documents Bates FOR WALMART: 22 SCOTT QUELLHORST, ESQ. 21 PDD9520512001, and JONES DAY PDD9520512259 through 23 77 West Wacker 22 2310....................... 92 Chicago, Illinois 60601 23 24 312-782-3939 24 squellhorst@jonesday.com 25 25 Golkow Litigation Services Page 2 (2 - 5) Case:Highly 1:17-md-02804-DAP Doc #: Confidential - 2177-20 SubjectFiled: 08/12/19 3Confidentiality to Further of 84. PageID #: 322529 Review Page 6 Page 8 1 1 Purdue-Wright-6 Criticisms and Purdue-Wright-26 Final Report - Top 200 2 Allegations Potentially 2 Project. January 2004, Requiring a Response in Bates PPLPC013000103821 3 Connection with the 3 through 3827............... 203 Senate Finance Committee 4 Purdue-Wright-27 PowerPoint, Risk 4 Inquiry, Bates Identification, Risk 5 Assessment and Management PPLPC018000725809 through of Drug Formulation (A 5 5863....................... 98 6 Regulated Company 6 Purdue-Wright-7 FDA meeting minutes, 7 Perspective)............... 215 Bates PKY180761078 7 through 1286............... 106 Purdue-Wright-28 PowerPoint, Data Analysis 8 Purdue-Wright-8 9/15/94 message with 8 Program, 1Q2004 Update, attached FDA meeting 9 Bates PPLPC013000106089.... 217 9 minutes, Bates Purdue-Wright-29 Dasgupta, et al paper, PDD7024302094 through 10 Association between 10 2104....................... 108 non-medical and 11 Purdue-Wright-9 OxyContin Investigator's 11 prescriptive usage of Brochure, May 1993, Bates 12 opioids.................... 224 12 PKY180919563 through 9618.. 116 Purdue-Wright-31 Medical Officer Review, 13 Purdue-Wright-10 11/11/93 memo, Bates 13 Integrated Summary of PKY181876119 through 121... 121 Safety, Bates 14 14 PDD1501090033 through 42... 235 Purdue-Wright-11 Project Team Contact 15 Purdue-Wright-32 Document titled 15 Report, Bates E01_00005654, Opioid-X PKY180723482 through 3484.. 124 16 Hecon...................... 247 16 17 Purdue-Wright-33 Document titled Purdue-Wright-12 Draft Meeting Minutes, Researched Abuse, 17 6/23/93, Bates 18 Diversion and PDD1701503232 through Addiction-Related 18 3245....................... 124 19 Surveillance (RADARS) System, Bates 8841350087... 252 19 Purdue-Wright-13 7/1/93 Memorandum, Bates 20 SHC-000007028 through Purdue-Wright-34 5/5/03 e-mail with 20 7032....................... 138 21 attached RADARS System 21 Purdue-Wright-14 Medical Officer Review, Report, Bates OxyContin, Bates 22 PPLPC013000094750 through 22 PDD1501090043 through 56... 141 23 94788...................... 253 23 Purdue-Wright-15 Project Team Contact Purdue-Wright-35 11/16/99 e-mail with Report, Bates 24 attachment, Bates 24 SHC-000008168.............. 148 PPLPC013000014822 through 25 25 14828...................... 254 Page 7 Page 9 1 1 Purdue-Wright-16 OxyContin package insert, Purdue-Wright-36 2/14/01 e-mail, with 2 Bates PKY183226682 2 attached OxyContin FDA through 6689............... 155 Negotiations Issues 3 3 Document, Bates Purdue-Wright-17 Document titled 8/2/95 PPLPC013000064640 through 4 Reder with attached 4 64643...................... 265 package insert, Bates 5 Purdue-Wright-37 Agenda for OxyContin 5 SHC-000004520 through Abuse/Diversion Meeting, 4545....................... 157 6 2/26/01, with attachment, 6 Bates PKY180277491 and Purdue-Wright-18 OxyContin meeting 7 492, 180715647, and 7 minutes, 4/23/01, Bates 180715649 through 651...... 270 PKY180715570 through 5576.. 161 8 8 Purdue-Wright-38 3/30/01 e-mail with Purdue-Wright-19 GAO Report, OxyContin 9 attached Risk Management 9 Abuse and Diversion and PowerPoint, Bates Efforts to Address the 10 PPLPC013000067001.......... 272 10 Problem, Bates 11 Purdue-Wright-39 Agreed Statement of Facts.. 277 PDD8013180635 through 697.. 169 12 Purdue-Wright-40 3/3/01 Regulatory Agency 11 Contact Report, Bates Purdue-Wright-20 PowerPoint, Bates 13 PPLP000666254 through 257.. 284 12 PKY180277573 through 7584.. 171 14 Purdue-Wright-41 Document titled 13 Purdue-Wright-21 PowerPoint, Clinical E513_00081940 with Summation, Bates 15 attached e-mail chain, 14 PPLPC013000068011.......... 175 Bates 8855931719 and 1720.. 286 15 Purdue-Wright-22 PowerPoint, Overall 16 Medical Strategy for Purdue-Wright-42 E-mail chain with 16 Purdue Opioid Products 17 attachment, Bates (Abuse and Diversion PPLPC009000043479 through 17 Resistance)," Bates 18 3485....................... 289 PDD8901212709 through 19 Purdue-Wright-43 E-mail with attached 18 2728....................... 180 document, Risk 19 Purdue-Wright-23 PowerPoint, 20 Assessment, Management Tamper-Resistance (What and Surveillance for 20 it is, What it isn't, 21 Prescription Opioids, What we need)," Bates 21 PPLPC013000094578.......... 185 Bates PPLPC013000096643 22 Purdue-Wright-24 Sponsor Meeting Minutes, 22 through 670................ 291 5/14/97, Bates 23 Purdue-Wright-44 2/13/13 deposition 23 PKY180816855 through 6858.. 193 transcript of Curtis 24 Purdue-Wright-25 1/6/01 e-mail, Bates 24 Wright, MD, Bates PDD8801176637 and 6638..... 201 PKY183393713 through 3804.. 292 25 25 Golkow Litigation Services Page 3 (6 - 9) Case:Highly 1:17-md-02804-DAP Doc #: Confidential - 2177-20 SubjectFiled: 08/12/19 4Confidentiality to Further of 84. PageID #: 322530 Review Page 10 Page 12 1 1 PROCEEDINGS Purdue-Wright-45 1/15/18 deposition 2 2 transcript of Curtis Wright, MD, Bates 3 THE VIDEOGRAPHER: We are now on the 3 PKY183389474 through 512... 297 4 Purdue-Wright-46 Excerpt of a 3/25/04 4 record. My name is David Kim, I'm a deposition transcript of 5 Dr. Robert Reder, Bates 5 videographer for Golkow Litigation Services. 6 PKY183344430 through 432... 297 6 Today's date is December 19th, 2018, Purdue-Wright-47 E-mail chain, Bates 7 PPLPC013000032858 through 7 and the time is 9:01 a.m. 860........................ 307 8 8 This video deposition is being held in Purdue-Wright-48 E-mail chain, Bates 9 Concord, New Hampshire in the matter of National 9 PPLPC013000040607 through 10 609........................ 308 10 Prescription Opiate Litigation, MDL 2804, for Purdue-Wright-49 Document titled 11 the U.S. District Court for the Northern 11 E513_00078820 with attached e-mail chain, 12 District of Ohio, Eastern Division. 12 Bates 8855884259 through 13 261........................ 309 13 The deponent is Curtis Wright. Purdue-Wright-50 Document titled 14 Counsel will be noted on the 14 E513_00078832 with 15 stenographic record. attached e-mail chain, 15 Bates 8855931438 through 16 The court reporter is Maureen Pollard, 16 440........................ 311 Purdue-Wright-51 Document titled 17 and will now swear in the witness. 17 E513_00019621 with 18 attached e-mail chain, 18 Bates 8855318499, 8500 19 CURTIS WRIGHT, IV, M.D., M.P.H., and 8005................... 311 19 20 having been duly sworn, was examined and Purdue-Wright-52 3/25/97 letter, Bates 21 testified as follows: 20 PKY180423619 through 621... 313 21 Purdue-Wright-53 E-mail chain, Bates 22 MR. SNAPP: May I make a statement on 22 8856452206 and 2207........ 314 Purdue-Wright-54 Document titled 23 the record about the confidentiality protective 23 E513_00082129 with 24 order? attached e-mail chain, 24 25 Bates 8856491648........... 318 25 MS. SINGER: Of course. Page 11 Page 13 1 1 MR. SNAPP: Thank you. Purdue-Wright-55 Excerpt of 8/28/15 2 I just want to confirm that everyone 2 deposition transcript of 3 on the phone and in person agrees to be bound by Richard Sackler, MD, 4 the confidentiality protective order in the MDL 3 Bates PPLPC019001253034, 5 or the applicable state cases. If that is not 3061 and 3062.............. 320 4 6 the case, please speak up now. 5 7 Hearing nothing, please proceed. 6 8 Thank you. 7 9 EXAMINATION 8 10 BY MS. SINGER: 9 11 Q. All righ